Renato A. Valdes Olmos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Renato A. Valdes Olmos has a total of 233 co-authors. Here are the top co-authors by number of shared publications:
- Sergi Vidal-Sicart
Department of Nuclear Medicine, Hospital Clinic of Barcelona, 08036 Barcelona, Spain
13 shared publications C A Hoefnagel
8 shared publicationsCornelis A. Hoefnagel
The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital
7 shared publications- Emiel J. Th. Rutgers
Department of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands
7 shared publications - Oscar Roberto Brouwer
The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital 1 Department of Urology Amsterdam, the Netherlands
7 shared publications Emiel J. Th. Rutgers
Department of Surgery, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
6 shared publications
Latest Publications
- Open Access
- 25 May 2017
- Published by Springer Nature in Cancer Imaging
- Vol. 17 (1) , 1-8
Additional value of 18F-FDG PET/CT response evaluation in axillary nodes during neoadjuvant therapy for triple-negative and HER2-positive breast cancer
18F-FDG PET/CT can monitor metabolic activity in early breast cancer during neoadjuvant systemic therapy (NST), but it is unknown if the metabolic breast and axillary response differ. We evaluated the correlation between metabolic breast and axillary response at various time points during NST. Furthermore, we analysed if the combined metabolic response improves pathologic complete response (pCR) prediction compared to using the metabolic breast response alone. 18F-FDG PET/CT was performed at baseline (PET1), 2–3 weeks (PET2), and 6–8 weeks (PET3) of NST in patients with triple-negative (TN) and HER2-positive node-positive breast cancer. SUVmax and ∆SUVmax were determined separately for breast and axilla. Spearman’s correlation coefficients (r) between both localisations were calculated. The accuracy of pCR total (ypT0/is,ypN0) prediction using the metabolic response in breast, axilla or both was examined using logistic regression analysis. Hundred-five patients were included: 45 TN and 60 HER2-positive tumours. The metabolic response in breast and axilla correlated moderately in TN tumours (r = 0.57) using ∆SUVmax between PET1-PET3 and poorly in HER2-positive tumours (r = 0.49) using SUVmax at PET2. In TN tumours, metabolic breast response predicted pCR well without improvement after adding axillary response (c-index 0.82 versus 0.85, p = 0.63). In HER2-positive tumours, metabolic breast response predicted pCR poorly with improvement after adding axillary response (c-index 0.64 versus 0.72, p = 0.06). 18F-FDG PET/CT response during NST differs between breast and axilla. In TN tumours, pCR total prediction can be made independent of metabolic axillary response. In HER2-positive tumours, axillary response may improve pCR total prediction. These findings may help guide PET/CT-response-based changes during NST. NTR NTR1797 . Registered 29 May 2009, retrospectively registered.
- 25 May 2017
- Published by Springer Nature in Cancer Imaging
- Vol. 17 (1) , 1-8
Open AccessAdditional value of 18F-FDG PET/CT response evaluation in axillary nodes during neoadjuvant therapy for triple-negative and HER2-positive breast cancer
18F-FDG PET/CT can monitor metabolic activity in early breast cancer during neoadjuvant systemic therapy (NST), but it is unknown if the metabolic breast and axillary response differ. We evaluated the correlation between metabolic breast and axillary response at various time points during NST. Furthermore, we analysed if the combined metabolic response improves pathologic complete response (pCR) prediction compared to using the metabolic breast response alone. 18F-FDG PET/CT was performed at baseline (PET1), 2–3 weeks (PET2), and 6–8 weeks (PET3) of NST in patients with triple-negative (TN) and HER2-positive node-positive breast cancer. SUVmax and ∆SUVmax were determined separately for breast and axilla. Spearman’s correlation coefficients (r) between both localisations were calculated. The accuracy of pCR total (ypT0/is,ypN0) prediction using the metabolic response in breast, axilla or both was examined using logistic regression analysis. Hundred-five patients were included: 45 TN and 60 HER2-positive tumours. The metabolic response in breast and axilla correlated moderately in TN tumours (r = 0.57) using ∆SUVmax between PET1-PET3 and poorly in HER2-positive tumours (r = 0.49) using SUVmax at PET2. In TN tumours, metabolic breast response predicted pCR well without improvement after adding axillary response (c-index 0.82 versus 0.85, p = 0.63). In HER2-positive tumours, metabolic breast response predicted pCR poorly with improvement after adding axillary response (c-index 0.64 versus 0.72, p = 0.06). 18F-FDG PET/CT response during NST differs between breast and axilla. In TN tumours, pCR total prediction can be made independent of metabolic axillary response. In HER2-positive tumours, axillary response may improve pCR total prediction. These findings may help guide PET/CT-response-based changes during NST. NTR NTR1797 . Registered 29 May 2009, retrospectively registered.
- 1 May 2017
- Published by Elsevier in Revista Española de Medicina Nuclear e Imagen Molecular
- Vol. 36 (3) , 158-165
A novel semi-robotized device for high-precision 18 F-FDG-guided breast cancer biopsy
- 1 May 2017
- Published by Elsevier in Revista Española de Medicina Nuclear e Imagen Molecular
- Vol. 36 (3) , 158-165
A novel semi-robotized device for high-precision 18 F-FDG-guided breast cancer biopsy
- 31 October 2016
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 43 (4) , 625-635
PET/CT with 18 F-FDG predicts short-term outcome in stage II/III breast cancer patients upstaged to N2/3 nodal disease
- 31 October 2016
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 43 (4) , 625-635
PET/CT with 18 F-FDG predicts short-term outcome in stage II/III breast cancer patients upstaged to N2/3 nodal disease
- Open Access
- 27 October 2016
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 44 (4) , 630-637
Contribution of SPECT/CT for sentinel node localization in patients with ipsilateral breast cancer relapse
In recent years repeat sentinel node (SN) biopsy has been proven to be feasible in local breast cancer recurrence (LBCR). However, in these patients SNs outside the ipsilateral axilla are frequently observed. This study evaluates the contribution of SPECT/CT for SN localization and surgical adjustment in LBCR patients.
- 27 October 2016
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 44 (4) , 630-637
Open AccessContribution of SPECT/CT for sentinel node localization in patients with ipsilateral breast cancer relapse
In recent years repeat sentinel node (SN) biopsy has been proven to be feasible in local breast cancer recurrence (LBCR). However, in these patients SNs outside the ipsilateral axilla are frequently observed. This study evaluates the contribution of SPECT/CT for SN localization and surgical adjustment in LBCR patients.
- Open Access
- 29 September 2016
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine
- Vol. 58 (4) , 646-650
Hybrid Surgical Guidance: Does Hardware Integration of γ- and Fluorescence Imaging Modalities Make Sense?
Introduction: The clinically applied hybrid tracer indocyanine green (ICG)-99mTc-nanocolloid enables combined radio- and fluorescence image guidance during sentinel node (SN) biopsy procedures. In order to provide optimal surgical guidance this tracer requires the presence of both gamma and fluorescence modalities in the operating room. We reasoned that combination and/or integration of these modalities could further evolve the hybrid surgical guidance concept. To study this potential we clinically applied two set-ups that included the combination of gamma detection modalities and an open surgery fluorescence camera. Methods: To attach the fluorescence camera (VITOM) to either 1) a gamma-ray detection probe (GP; VITOM-GP) or 2) a portable gamma camera (GC) (VITOM-GC), clip-on brackets were designed and 3D-printed in sterilizable RC31. Both combined modalities were evaluated in respectively five and six patients with penile cancer during a SN biopsy procedure using ICG-99mTc-nanocolloid. Intraoperatively, radio- and fluorescence guided SN detection rates were scored at working distances of 0, 10, 20, and 30 cm for both combinations. Results: Using the VITOM-GP combination 9 SNs were evaluated. Gamma tracing rates were shown to be 100, 88.9, 55.6 and 55.6 % at a respective working distance of 0, 10, 20 and 30 cm. Detection rates for the fluorescence imaging-based detection were found to be 100, 77.8 and 77.8 %, at respective working distances of 10, 20, and 30 cm. Using the VITOM-GC set-up, all 10 intraoperatively evaluated SNs could be visualized with the gamma camera independent of the working distance. Fluorescence detection rates were 90, 80 and 80% at 10, 20 and 30cm working distance. The integrated detection modalities were shown to work synergistically; overall the GC was most valuable for rough localization (10-30 cm range) of the SNs, the GP for providing convenient real-time acoustic feedback, while fluorescence guidance allowed detailed real-time SN visualization. Conclusion: Our findings suggest that full integration of a fluorescence camera with gamma detector (GP or GC) can be of value when a hybrid, radioactive and fluorescent, tracer is used.
- 29 September 2016
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine
- Vol. 58 (4) , 646-650
Open AccessHybrid Surgical Guidance: Does Hardware Integration of γ- and Fluorescence Imaging Modalities Make Sense?
Introduction: The clinically applied hybrid tracer indocyanine green (ICG)-99mTc-nanocolloid enables combined radio- and fluorescence image guidance during sentinel node (SN) biopsy procedures. In order to provide optimal surgical guidance this tracer requires the presence of both gamma and fluorescence modalities in the operating room. We reasoned that combination and/or integration of these modalities could further evolve the hybrid surgical guidance concept. To study this potential we clinically applied two set-ups that included the combination of gamma detection modalities and an open surgery fluorescence camera. Methods: To attach the fluorescence camera (VITOM) to either 1) a gamma-ray detection probe (GP; VITOM-GP) or 2) a portable gamma camera (GC) (VITOM-GC), clip-on brackets were designed and 3D-printed in sterilizable RC31. Both combined modalities were evaluated in respectively five and six patients with penile cancer during a SN biopsy procedure using ICG-99mTc-nanocolloid. Intraoperatively, radio- and fluorescence guided SN detection rates were scored at working distances of 0, 10, 20, and 30 cm for both combinations. Results: Using the VITOM-GP combination 9 SNs were evaluated. Gamma tracing rates were shown to be 100, 88.9, 55.6 and 55.6 % at a respective working distance of 0, 10, 20 and 30 cm. Detection rates for the fluorescence imaging-based detection were found to be 100, 77.8 and 77.8 %, at respective working distances of 10, 20, and 30 cm. Using the VITOM-GC set-up, all 10 intraoperatively evaluated SNs could be visualized with the gamma camera independent of the working distance. Fluorescence detection rates were 90, 80 and 80% at 10, 20 and 30cm working distance. The integrated detection modalities were shown to work synergistically; overall the GC was most valuable for rough localization (10-30 cm range) of the SNs, the GP for providing convenient real-time acoustic feedback, while fluorescence guidance allowed detailed real-time SN visualization. Conclusion: Our findings suggest that full integration of a fluorescence camera with gamma detector (GP or GC) can be of value when a hybrid, radioactive and fluorescent, tracer is used.
- 1 September 2016
- Published by Elsevier in Revista Española de Medicina Nuclear e Imagen Molecular
- Vol. 35 (5) , 292-297
Hybrid radioguided occult lesion localization (hybrid ROLL) of 18F-FDG-avid lesions using the hybrid tracer indocyanine green-99mTc-nanocolloid
- 1 September 2016
- Published by Elsevier in Revista Española de Medicina Nuclear e Imagen Molecular
- Vol. 35 (5) , 292-297
Hybrid radioguided occult lesion localization (hybrid ROLL) of 18F-FDG-avid lesions using the hybrid tracer indocyanine green-99mTc-nanocolloid
- 1 August 2016
- Published by Wolters Kluwer Health in Nuclear Medicine Communications
- Vol. 37 (8) , 812-817
A pilot study of SPECT/CT-based mixed-reality navigation towards the sentinel node in patients with melanoma or Merkel cell carcinoma of a lower extremity
Objective To explore the feasibility of an intraoperative navigation technology based on preoperatively acquired single photon emission computed tomography combined with computed tomography (SPECT/CT) images during sentinel node (SN) biopsy in patients with melanoma or Merkel cell carcinoma. Materials and methods Patients with a melanoma (n=4) or Merkel cell carcinoma (n=1) of a lower extremity scheduled for wide re-excision of the primary lesion site and SN biopsy were studied. Following a 99mTc-nanocolloid injection and lymphoscintigraphy, SPECT/CT images were acquired with a reference target (ReTp) fixed on the leg or the iliac spine. Intraoperatively, a sterile ReTp was placed at the same site to enable SPECT/CT-based mixed-reality navigation of a gamma ray detection probe also containing a reference target (ReTgp). The accuracy of the navigation procedure was determined in the coronal plane (x, y-axis) by measuring the discrepancy between standard gamma probe-based SN localization and mixed-reality-based navigation to the SN. To determine the depth accuracy (z-axis), the depth estimation provided by the navigation system was compared to the skin surface-to-node distance measured in the computed tomography component of the SPECT/CT images. Results In four of five patients, it was possible to navigate towards the preoperatively defined SN. The average navigational error was 8.0 mm in the sagittal direction and 8.5 mm in the coronal direction. Intraoperative sterile ReTp positioning and tissue movement during surgery exerted a distinct influence on the accuracy of navigation. Conclusion Intraoperative navigation during melanoma or Merkel cell carcinoma surgery is feasible and can provide the surgeon with an interactive 3D roadmap towards the SN or SNs in the groin. However, further technical optimization of the modality is required before this technology can become routine practice.
- 1 August 2016
- Published by Wolters Kluwer Health in Nuclear Medicine Communications
- Vol. 37 (8) , 812-817
A pilot study of SPECT/CT-based mixed-reality navigation towards the sentinel node in patients with melanoma or Merkel cell carcinoma of a lower extremity
Objective To explore the feasibility of an intraoperative navigation technology based on preoperatively acquired single photon emission computed tomography combined with computed tomography (SPECT/CT) images during sentinel node (SN) biopsy in patients with melanoma or Merkel cell carcinoma. Materials and methods Patients with a melanoma (n=4) or Merkel cell carcinoma (n=1) of a lower extremity scheduled for wide re-excision of the primary lesion site and SN biopsy were studied. Following a 99mTc-nanocolloid injection and lymphoscintigraphy, SPECT/CT images were acquired with a reference target (ReTp) fixed on the leg or the iliac spine. Intraoperatively, a sterile ReTp was placed at the same site to enable SPECT/CT-based mixed-reality navigation of a gamma ray detection probe also containing a reference target (ReTgp). The accuracy of the navigation procedure was determined in the coronal plane (x, y-axis) by measuring the discrepancy between standard gamma probe-based SN localization and mixed-reality-based navigation to the SN. To determine the depth accuracy (z-axis), the depth estimation provided by the navigation system was compared to the skin surface-to-node distance measured in the computed tomography component of the SPECT/CT images. Results In four of five patients, it was possible to navigate towards the preoperatively defined SN. The average navigational error was 8.0 mm in the sagittal direction and 8.5 mm in the coronal direction. Intraoperative sterile ReTp positioning and tissue movement during surgery exerted a distinct influence on the accuracy of navigation. Conclusion Intraoperative navigation during melanoma or Merkel cell carcinoma surgery is feasible and can provide the surgeon with an interactive 3D roadmap towards the SN or SNs in the groin. However, further technical optimization of the modality is required before this technology can become routine practice.
- 1 June 2016
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 206 (6) , 1307-1314
Evaluation of a Hanging-Breast PET System for Primary Tumor Visualization in Patients With Stage I–III Breast Cancer: Comparison With Standard PET/CT
OBJECTIVE. The purposes of this study were to evaluate the performance of a mammography with molecular imaging PET (MAMMI-PET) system for breast imaging in the hanging-breast position for the visualization of primary breast cancer lesions and to compare this method with whole-body PET/CT. SUBJECTS AND METHODS. Between March 2011 and March 2014, a prospective evaluation included women with one or more histologically confirmed primary breast cancer lesions (index lesions). After injection of 180–240 MBq of 18F-FDG, whole-body PET/CT and MAMMI-PET acquisitions were performed, index lesions were scored 0, 1, or 2 for FDG uptake relative to background. Detection and FDG uptake were compared by breast length, maximal tumor diameter, affected breast quadrants, tumor grade, and histologic and immunologic sub-types. Finally, the two PET modalities were compared for detection of index lesions. RESULTS. For 234 index lesions (diameter, 5–170 mm), the overall sensitivity was 88.9% for MAMMI-PET and 91% for PET/CT (p ...
- 1 June 2016
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 206 (6) , 1307-1314
Evaluation of a Hanging-Breast PET System for Primary Tumor Visualization in Patients With Stage I–III Breast Cancer: Comparison With Standard PET/CT
OBJECTIVE. The purposes of this study were to evaluate the performance of a mammography with molecular imaging PET (MAMMI-PET) system for breast imaging in the hanging-breast position for the visualization of primary breast cancer lesions and to compare this method with whole-body PET/CT. SUBJECTS AND METHODS. Between March 2011 and March 2014, a prospective evaluation included women with one or more histologically confirmed primary breast cancer lesions (index lesions). After injection of 180–240 MBq of 18F-FDG, whole-body PET/CT and MAMMI-PET acquisitions were performed, index lesions were scored 0, 1, or 2 for FDG uptake relative to background. Detection and FDG uptake were compared by breast length, maximal tumor diameter, affected breast quadrants, tumor grade, and histologic and immunologic sub-types. Finally, the two PET modalities were compared for detection of index lesions. RESULTS. For 234 index lesions (diameter, 5–170 mm), the overall sensitivity was 88.9% for MAMMI-PET and 91% for PET/CT (p ...
- 1 May 2016
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 41 (5) , e216-e220
Intraoperative 3D Navigation for Single or Multiple 125I-Seed Localization in Breast-Preserving Cancer Surgery
Mammographic screening has led to the identification of more women with nonpalpable breast cancer, many of them to be treated with breast-preserving surgery. To accomplish radical tumor excision, adequate localization techniques such as radioactive seed localization (RSL) are required. For RSL, a radioactive I-seed is implanted central in the tumor to enable intraoperative localization using a γ-probe. In case of extensive tumor or multifocal carcinoma, multiple I-seeds can be used to delineate the involved area. Preoperative imaging is performed different from surgical positioning; therefore, exact I-seed depth remains unknown during surgery. Twenty patients (mean age, 56.8 years) with 25 implanted I-seeds scheduled for RSL were included. Sixteen patients had 1 I-seed implanted in the primary lesion, 3 patients had 2 I-seeds, and 1 patient had 3 I-seeds. Freehand SPECT localized I-seeds by measuring γ-counts from different directions, all registered by an optical tracking system. A reconstruction and visualization algorithm enabled 3-dimensional (3D) navigation toward the I-seeds. Freehand SPECT visualized all I-seeds in primary tumors and provided preincision depth information. The deviation, mean (SD), between the freehand SPECT depth and the surgical depth estimation was 1.9 (2.1) mm (range, 0-7 mm). Three-dimensional freehand SPECT was especially useful identifying multiple implanted I-seeds because the conventional γ-probe has more difficulty discriminating I-seeds transcutaneous. Freehand SPECT with 3D navigation is a valuable tool in RSL for both single and multiple implanted I-seeds in breast-preserving cancer surgery. Freehand SPECT provides continuous updating 3D imaging with information about depth and location of the I-seeds contributing to adequate excision of nonpalpable breast cancer.
- 1 May 2016
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 41 (5) , e216-e220
Intraoperative 3D Navigation for Single or Multiple 125I-Seed Localization in Breast-Preserving Cancer Surgery
Mammographic screening has led to the identification of more women with nonpalpable breast cancer, many of them to be treated with breast-preserving surgery. To accomplish radical tumor excision, adequate localization techniques such as radioactive seed localization (RSL) are required. For RSL, a radioactive I-seed is implanted central in the tumor to enable intraoperative localization using a γ-probe. In case of extensive tumor or multifocal carcinoma, multiple I-seeds can be used to delineate the involved area. Preoperative imaging is performed different from surgical positioning; therefore, exact I-seed depth remains unknown during surgery. Twenty patients (mean age, 56.8 years) with 25 implanted I-seeds scheduled for RSL were included. Sixteen patients had 1 I-seed implanted in the primary lesion, 3 patients had 2 I-seeds, and 1 patient had 3 I-seeds. Freehand SPECT localized I-seeds by measuring γ-counts from different directions, all registered by an optical tracking system. A reconstruction and visualization algorithm enabled 3-dimensional (3D) navigation toward the I-seeds. Freehand SPECT visualized all I-seeds in primary tumors and provided preincision depth information. The deviation, mean (SD), between the freehand SPECT depth and the surgical depth estimation was 1.9 (2.1) mm (range, 0-7 mm). Three-dimensional freehand SPECT was especially useful identifying multiple implanted I-seeds because the conventional γ-probe has more difficulty discriminating I-seeds transcutaneous. Freehand SPECT with 3D navigation is a valuable tool in RSL for both single and multiple implanted I-seeds in breast-preserving cancer surgery. Freehand SPECT provides continuous updating 3D imaging with information about depth and location of the I-seeds contributing to adequate excision of nonpalpable breast cancer.